These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 36662242)

  • 1. [Clonal hematopoiesis: causes and clinical implications].
    Burchert A
    Z Gerontol Geriatr; 2023 Feb; 56(1):65-72. PubMed ID: 36662242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clonal hematopoiesis: causes and clinical implications].
    Burchert A
    Inn Med (Heidelb); 2022 Oct; 63(10):1051-1058. PubMed ID: 35969263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal hematopoiesis of indeterminate potential and cardiovascular disease.
    Saadatagah S; Ballantyne CM
    Transl Res; 2023 May; 255():152-158. PubMed ID: 36067904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation.
    Goldman EA; Spellman PT; Agarwal A
    Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 36889927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal hematopoiesis: Molecular and clinical implications.
    Kusne Y; Xie Z; Patnaik MM
    Leuk Res; 2022 Feb; 113():106787. PubMed ID: 35091334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHIP Happens: Clonal Hematopoiesis of Indeterminate Potential and Its Relationship to Solid Tumors.
    Reed SC; Croessmann S; Park BH
    Clin Cancer Res; 2023 Apr; 29(8):1403-1411. PubMed ID: 36454121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal Hematopoiesis and Its Impact on Human Health.
    Ahmad H; Jahn N; Jaiswal S
    Annu Rev Med; 2023 Jan; 74():249-260. PubMed ID: 36450282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies.
    Marshall CH; Gondek LP; Luo J; Antonarakis ES
    Cancer Res; 2022 Nov; 82(22):4107-4113. PubMed ID: 36040522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clonal hematopoiesis: a risk factor for leukemia and cardiovascular disease?].
    van Zeventer IA; Buisman SC; de Graaf AO; de Haan G; Jansen JH; Huls G
    Ned Tijdschr Geneeskd; 2020 Nov; 164():. PubMed ID: 33331716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aging and clonal hematopoesis.].
    Bogdanov AN; Voloshin SV; Kunevich EO; Mikhaleva MA
    Adv Gerontol; 2024; 37(3):266-275. PubMed ID: 39139119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Implications of Clonal Hematopoiesis.
    Steensma DP
    Mayo Clin Proc; 2018 Aug; 93(8):1122-1130. PubMed ID: 30078412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Importance of clonal hematopoiesis for hematologic neoplasms].
    Götze KS; Lengerke C
    Inn Med (Heidelb); 2022 Nov; 63(11):1107-1114. PubMed ID: 36125513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Disease.
    Kumar P; Kopecky SL; Yang EH; Oren O
    Curr Oncol Rep; 2020 Jul; 22(9):87. PubMed ID: 32643015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal hematopoiesis and associated diseases: A review of recent findings.
    Asada S; Kitamura T
    Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical consequences of clonal hematopoiesis of indeterminate potential.
    Steensma DP
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):264-269. PubMed ID: 30504320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal hematopoiesis, somatic mosaicism, and age-associated disease.
    Evans MA; Walsh K
    Physiol Rev; 2023 Jan; 103(1):649-716. PubMed ID: 36049115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.
    Marnell CS; Bick A; Natarajan P
    J Mol Cell Cardiol; 2021 Dec; 161():98-105. PubMed ID: 34298011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions.
    Singh I; Singh A
    Curr Oncol Rep; 2023 Jun; 25(6):539-547. PubMed ID: 36928826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
    Gumuser ED; Schuermans A; Cho SMJ; Sporn ZA; Uddin MM; Paruchuri K; Nakao T; Yu Z; Haidermota S; Hornsby W; Weeks LD; Niroula A; Jaiswal S; Libby P; Ebert BL; Bick AG; Natarajan P; Honigberg MC
    J Am Coll Cardiol; 2023 May; 81(20):1996-2009. PubMed ID: 37197843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical consequences of clonal hematopoiesis of indeterminate potential.
    Steensma DP
    Blood Adv; 2018 Nov; 2(22):3404-3410. PubMed ID: 30482770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.